Gå til innholdet
Global sound
BioBiz Buzz

BioBiz Buzz

13. Tackling the undruggable: How Beactica's protein degradation platform might transform glioblastoma treatment

· 32 min · Sesong 1 Episode 13

Episodebeskrivelse

Targeted protein degradation (TPD) represents one of the most transformative advances in drug discovery, with the global market projected to expand from USD 641 million in 2025 to as much as USD 9.85 billion by 2035. This rapidly evolving field enables researchers to eliminate disease-causing proteins rather than merely inhibiting their function, offering unprecedented opportunities to tackle previously "undruggable" targets that have eluded conventional therapeutic approaches with the ...

Live, siste time: 9 590 låter på 4 446 stasjoner i 114 land

Oppdag verden gjennom radioen

Flere måter å oppdage på (7)

Hørt noe fint? Lagre det, eller åpne det rett i Spotify.

★ Artist of the week The fastest riser on the radio this week
Your song here? From € 9 per week →
Radio WPLNFortsett å lytte